204 related articles for article (PubMed ID: 33016805)
1. Three-Year Outcomes From the LIBERTY 360 Study of Endovascular Interventions for Peripheral Artery Disease Stratified by Rutherford Category.
Giannopoulos S; Mustapha J; Gray WA; Ansel G; Adams G; Secemsky EA; Armstrong EJ
J Endovasc Ther; 2021 Apr; 28(2):262-274. PubMed ID: 33016805
[TBL] [Abstract][Full Text] [Related]
2. One-Year Results of the LIBERTY 360 Study: Evaluation of Acute and Midterm Clinical Outcomes of Peripheral Endovascular Device Interventions.
Mustapha J; Gray W; Martinsen BJ; Bolduan RW; Adams GL; Ansel G; Jaff MR
J Endovasc Ther; 2019 Apr; 26(2):143-154. PubMed ID: 30722718
[TBL] [Abstract][Full Text] [Related]
3. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.
Giannopoulos S; Secemsky EA; Mustapha JA; Adams G; Beasley RE; Pliagas G; Armstrong EJ
J Endovasc Ther; 2020 Oct; 27(5):714-725. PubMed ID: 32618486
[No Abstract] [Full Text] [Related]
4. One-Year Outcomes of Peripheral Endovascular Device Intervention in Critical Limb Ischemia Patients: Sub-Analysis of the LIBERTY 360 Study.
Mustapha JA; Igyarto Z; O'Connor D; Armstrong EJ; Iorio AR; Driver VR; Saab F; Behrens AN; Martinsen BJ; Adams GL
Vasc Health Risk Manag; 2020; 16():57-66. PubMed ID: 32103970
[TBL] [Abstract][Full Text] [Related]
5. Anterior, posterior, or all-vessel infrapopliteal revascularization in patients with moderate-severe claudication: Insights from the LIBERTY 360 study.
Salahuddin T; Giannopoulos S; Adams G; Armstrong EJ
Catheter Cardiovasc Interv; 2021 Sep; 98(3):559-569. PubMed ID: 34057276
[TBL] [Abstract][Full Text] [Related]
6. Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial.
Magnuson EA; Li H; Vilain K; Armstrong EJ; Secemsky EA; Giannopoulos S; Adams GL; Mustapha J; Cohen DJ;
J Med Econ; 2021; 24(1):570-580. PubMed ID: 33866936
[TBL] [Abstract][Full Text] [Related]
7. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
[TBL] [Abstract][Full Text] [Related]
8. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
10. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
[TBL] [Abstract][Full Text] [Related]
11. Sex-Related Differences in the Outcomes of Endovascular Interventions for Chronic Limb-Threatening Ischemia: Results from the LIBERTY 360 Study.
Giannopoulos S; Shammas NW; Cawich I; Staniloae CS; Adams GL; Armstrong EJ
Vasc Health Risk Manag; 2020; 16():271-284. PubMed ID: 32753875
[TBL] [Abstract][Full Text] [Related]
12. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.
Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S;
JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Endovascular Therapy for Upper Extremity Peripheral Artery Disease With Critical Hand Ischemia.
Tomoi Y; Soga Y; Fujihara M; Iida O; Shintani Y; Zen K; Ando K
J Endovasc Ther; 2016 Oct; 23(5):717-22. PubMed ID: 27421289
[TBL] [Abstract][Full Text] [Related]
14. Outcomes After Endovascular Revascularization in Octogenarians and Non-Octogenarians With Critical Limb Ischemia.
Uhl C; Steinbauer M; Torsello G; Bisdas T;
J Endovasc Ther; 2017 Aug; 24(4):471-477. PubMed ID: 28578624
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease.
Weissler EH; Narcisse DI; Rymer JA; Armstrong EJ; Secemsky E; Gray WA; Mustapha JA; Adams GL; Ansel GM; Patel MR; Jones WS
Vasc Endovascular Surg; 2021 Feb; 55(2):124-134. PubMed ID: 33094679
[TBL] [Abstract][Full Text] [Related]
16. Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization.
Malgor RD; Ricotta JJ; Bower TC; Oderich GS; Kalra M; Duncan AA; Gloviczki P
Ann Vasc Surg; 2012 Oct; 26(7):946-56. PubMed ID: 22944568
[TBL] [Abstract][Full Text] [Related]
17. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
18. Early and Midterm Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Asian Patients With Chronic Limb-Threatening Ischemia: One-Year Clinical and Imaging Outcomes From the DISAPEAR Registry.
Kum S; Ipema J; Chun-Yin DH; Lim DM; Tan YK; Varcoe RL; Hazenberg CEVB; Ünlü Ç
J Endovasc Ther; 2020 Aug; 27(4):616-622. PubMed ID: 32469296
[No Abstract] [Full Text] [Related]
19. Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.
Perlander A; Jivegård L; Nordanstig J; Svensson M; Österberg K
J Vasc Surg; 2020 Dec; 72(6):1987-1995. PubMed ID: 32276010
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Clinical Outcomes After Revascularization in Patients With Chronic Limb-Threatening Ischemia: Results From a Prospective National Cohort Study (RIVALUTANDO).
de Donato G; Benedetto F; Stilo F; Chiesa R; Palombo D; Pasqui E; Panzano C; Pulli R; Novali C; Silingardi R; Grego F; Palasciano G; Setacci C;
Angiology; 2021 May; 72(5):480-489. PubMed ID: 33406850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
